T

Trovagene

32 employees

Cardiff Oncology is develops drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Mutation Detection
Cancer Monitoring
Response Monitoring
Health Diagnostics
Medical
Health Care
Oncology

Date founded

1999

Funding rounds raised

Total raised

$15M

from 2 investors over 2 rounds

T

Trovagene raised $14M on June 16, 2020

Investors: Acorn Bioventures

T

Trovagene raised $15M on July 1, 2014

Investors: Oxford Finance LLC

FAQ